897 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
GSK GlaxoSmithKline PLC $39.21 $97.25B Buy
Article Searches
Emergent (EBS) Files Application for Emergency Use of NuThrax http://www.zacks.com/stock/news/345130/emergent-ebs-files-application-for-emergency-use-of-nuthrax?cid=CS-ZC-FT-345130 Dec 31, 2018 - Emergent (EBS) submits an application to the FDA for the emergency use of its anthrax vaccine candidate, NuThrax.
Big Pharma Tapping Genetic Testing Companies for Data to Speed Drug Development http://www.gurufocus.com/news/791500/big-pharma-tapping-genetic-testing-companies-for-data-to-speed-drug-development Dec 27, 2018 - Big Pharma Tapping Genetic Testing Companies for Data to Speed Drug Development, Stocks: DGX,LH,MYGN,ILMN,RO,PFE,GSK, release date:Dec 26, 2018
Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations http://www.zacks.com/stock/news/344133/pharma-stock-roundup-gsk-pfe-ink-consumer-health-jv-jnj-hit-by-talc-allegations?cid=CS-ZC-FT-344133 Dec 21, 2018 - Glaxo (GSK) and Pfizer (PFE) agree to merge their consumer healthcare units into a new JV. J&J stock hit by reports alleging it of being aware of the presence of asbestos in baby powder.
Merck's sBLA for Keytruda in Lung Cancer Gets Extended Review http://www.zacks.com/stock/news/344112/mercks-sbla-for-keytruda-in-lung-cancer-gets-extended-review?cid=CS-ZC-FT-344112 Dec 21, 2018 - FDA extends review period for label expansion application for Merck's (MRK) Keytruda in first-line lung cancer by three months. A decision is now expected in April 2019.
Novartis (NVS) Offers to Buy French Gene Therapy Manufacturer http://www.zacks.com/stock/news/344105/novartis-nvs-offers-to-buy-french-gene-therapy-manufacturer?cid=CS-ZC-FT-344105 Dec 21, 2018 - Novartis (NVS) looks to buy French company, CellforCure to expand manufacturing capacity for innovative cell and gene therapies.
Pfizer: Consumer Health Deal Looks Good https://seekingalpha.com/article/4229392-pfizer-consumer-health-deal-looks-good?source=feed_sector_healthcare Dec 20, 2018 - Pfizer is combining its consumer business unit in a smart deal with that of GSK.I like the deal which looks smart but is too small to impact Pfizer in a big way.Shares have seen some solid gains in re
Company News For Dec 20, 2018 http://www.zacks.com/stock/news/343908/company-news-for-dec-20-2018?cid=CS-ZC--343908 Dec 20, 2018 - Companies In The News Are: FDX,GIS,LLY,PFE,GSK
GlaxoSmithKline, Pfizer Team Up to Form New Joint Venture http://www.gurufocus.com/news/788521/glaxosmithkline-pfizer-team-up-to-form-new-joint-venture Dec 19, 2018 - GlaxoSmithKline, Pfizer Team Up to Form New Joint Venture, Stocks: GSK,PFE, release date:Dec 19, 2018
Stocks making the biggest moves premarket: GIS, UAA, FDX, FB, JNJ & more https://www.cnbc.com/2018/12/19/stocks-making-the-biggest-moves-premarket-gis-uaa-fdx-fb-jnj--more.html Dec 19, 2018 - Names on the move ahead of the open.
One Rate Hike Over The Line (Wall Street Breakfast Podcast) https://seekingalpha.com/article/4229157-one-rate-hike-line-wall-street-breakfast-podcast?source=feed_all_articles Dec 19, 2018 - Today's Top Stories: One rate hike over the line; Italy reaches informal agreement with EU over budget plan; and Softbank plunges in IPO debut. If you are interested in listening to Wall Street Breakf

Pages: 12345678910...90

<<<Page 5>